Hematopoietic Stem Cell Transplant for Blood Cancers
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
- Age
- 18 – 120
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Wake Forest University Health Sciences · Other
This trial is looking for patients who are scheduled for a stem cell transplant due to certain blood cancers. Participants will help researchers by providing information during their treatment.
You may be able to join if
- I am planned to receive a standard care dose of intensive therapy.
- I am scheduled for either an allogeneic or autologous bone marrow transplant.
You may not be able to join if
- I am participating in any other treatment research protocol.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityTo provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.
Loading trial locations…